Global Blood Group Typing Industry, Forecast to 2028

Description

Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities

This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anemia, thalassemia, lymphoma, leukemia, and hemophilia, is also supporting the growth of blood group typing. Technological advances, including automated analyzers and antiglobulin screening tools, are revolutionizing clinical outcomes and enhancing blood compatibility. Major market players are prioritizing research and development (R&D) investments to offer innovative devices, improve safety, enhance storage duration, and promote industry growth. Strategic partnerships and alliances are becoming more popular in this competitive environment, allowing industry participants to broaden their product offerings and improve their worldwide presence.

The study offers relevant forecasts for this industry by region (North America, Europe, Asia-Pacific, and the rest of the world), test type (ABO blood tests & Rh typing, antibody screening, HLA typing, antigen typing, and others), and end users (hospitals, blood banks, clinical laboratories, and others). It analyzes the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for stakeholders and market players to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.

Product Code: K993-55

Summary

Growth Imperatives

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Blood Group Typing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of the Study
Test Type Segmentation
End-user Segmentation

Blood Group Typing-Overview

Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Region
Revenue Forecast Analysis by Region-North America
Revenue Forecast Analysis by Region-Europe
Revenue Forecast Analysis by Region-Asia-Pacific
Revenue Forecast Analysis by Region-RoW
Revenue Forecast by Test Type Segment
Revenue Forecast by End User
Revenue Forecast by End User Analysis
Pricing Trends and Analysis
Key Pricing Strategies Adopted by Players
Factors Expected to Influence Pricing
Global Blood Group Typing Industry-Notable Activities
Blood Group Typing Reimbursement Pathways by Country
Competitive Environment

Competitive Landscape

Key Competitors and Industry Players
Revenue Share by Player
Company Product Portfolio Analysis-Competitive Benchmarking of Industry Players by Key Parameter

Companies to Watch

Companies to Watch

Growth Opportunity Universe

Growth Opportunity 1: Strategic Automation Integration to Revolutionize Blood Group Testing
Growth Opportunity 2: Remote Blood Group Testing Solutions for Enhanced Accessibility
Growth Opportunity 3: Expansion of Blood Typing Services in Underserved Regions
Growth Opportunity 4: Collaborations with Telehealth Platforms for Integrated Blood Group Services
Growth Opportunity Summary

Next Steps

Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer